Data / Form D filings / Alloplex Biotherapeutics, Inc.
Alloplex Biotherapeutics, Inc.: Form D filings
Alloplex Biotherapeutics, Inc., a biotechnology company in Woburn, MA, filed 3 Form D notices with the SEC between 2019 and 2023. The latest, on February 13, 2023, reports $20.7 million sold of a $25 million offering to 51 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300 Trade Center Drive, Suite 6580, Woburn, MA, 01801
- Phone
- (857) 272-1214
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1762917
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 13, 2023 | New notice | $25,000,000 | $20,670,582 | $4,329,418 | 51 | Jan 27, 2023 | sec.gov |
| Jul 26, 2019 | New notice | Indefinite | $200,000 | 2 | Jul 17, 2019 | sec.gov | |
| Jan 2, 2019 | New notice | $2,000,000 | $200,000 | $1,800,000 | 2 | Dec 18, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Francescopalo Borriello | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Feb 13, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Alloplex Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.